TGTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 10.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $781,496.86

TG Therapeutics Insider Trading History Chart

TG Therapeutics Share Price & Price History

^$39.86

▼ -0.34 (-0.85%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

TG Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/6/2025	Sean A. Power	CFO	Sell	10,021	$28.53	$285,899.13	660,611
1/3/2025	Sean A. Power	CFO	Sell	11,337	$30.29	$343,397.73	670,632
11/11/2024	Sagar Lonial	Director	Sell	5,000	$30.44	$152,200.00	100,195
3/12/2024	Laurence N. Charney	Director	Sell	22,000	$15.97	$351,340.00	215,229
1/5/2024	Laurence N. Charney	Director	Sell	17,500	$19.03	$333,025.00	237,229
1/3/2024	Sean A. Power	CFO	Sell	47,867	$16.91	$809,430.97	606,969
8/11/2023	Michael S. Weiss	CEO	Buy	100,000	$10.13	$1,013,000.00	12,073,021
6/23/2023	Sagar Lonial	Director	Sell	34,854	$23.37	$814,537.98	93,878
6/2/2023	Sean A. Power	CFO	Sell	73,647	$26.70	$1,966,374.90	654,836
1/6/2023	Yann Echelard	Director	Buy	9,000	$10.64	$95,760.00	201,848
1/4/2023	Laurence N. Charney	Director	Sell	30,000	$11.10	$333,000.00	234,729

See Full Table

SEC Filings (Institutional Ownership Changes) for TG Therapeutics (NASDAQ:TGTX)

58.58% of TG Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

TG Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	63,513	$1.91M	0.0%	-13.4%	0.040%
3/18/2025	California State Teachers Retirement System	137,002	$4.12M	0.0%	-1.0%	0.087%
3/18/2025	CWC Advisors LLC.	13,700	$0.41M	0.4%	-15.2%	0.009%
3/17/2025	NorthCrest Asset Manangement LLC	14,890	$0.45M	0.0%	N/A	0.009%
2/21/2025	Vermillion Wealth Management Inc.	1,000	$30K	0.0%	N/A	0.001%
2/20/2025	Mackenzie Financial Corp	8,888	$0.27M	0.0%	-46.1%	0.006%
2/18/2025	Connecticut Wealth Management LLC	14,782	$0.45M	0.0%	-46.8%	0.009%
2/18/2025	Castleark Management LLC	211,370	$6.36M	0.2%	+25.2%	0.136%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	272,370	$8.20M	0.0%	-7.3%	0.175%
2/17/2025	Soleus Capital Management L.P.	2,681,242	$80.71M	5.1%	+5.8%	1.722%
2/17/2025	Wexford Capital LP	14,000	$0.42M	0.1%	N/A	0.009%
2/17/2025	Two Sigma Advisers LP	10,700	$0.32M	0.0%	-95.3%	0.007%
2/17/2025	Two Sigma Investments LP	606,208	$18.25M	0.0%	-43.0%	0.389%
2/17/2025	Rafferty Asset Management LLC	331,412	$9.98M	0.0%	-2.7%	0.213%
2/17/2025	Redwood Investments LLC	94,554	$2.85M	0.8%	+0.9%	0.061%
2/17/2025	ProShare Advisors LLC	41,955	$1.26M	0.0%	+44.7%	0.027%
2/17/2025	Man Group plc	9,589	$0.29M	0.0%	N/A	0.006%
2/17/2025	Nicholas Investment Partners LP	84,147	$2.53M	0.2%	-23.3%	0.054%
2/17/2025	Nuveen Asset Management LLC	1,798,989	$54.15M	0.0%	-11.4%	1.156%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	92,683	$2.81M	0.0%	+3.2%	0.060%
2/17/2025	Lazard Asset Management LLC	6,376	$0.19M	0.0%	-31.8%	0.004%
2/17/2025	Integral Health Asset Management LLC	150,000	$4.52M	0.4%	N/A	0.096%
2/17/2025	J. Goldman & Co LP	8,036	$0.24M	0.0%	-81.2%	0.005%
2/17/2025	Jacobs Levy Equity Management Inc.	84,589	$2.55M	0.0%	-53.1%	0.054%
2/17/2025	Gotham Asset Management LLC	50,949	$1.53M	0.0%	-55.8%	0.033%
2/17/2025	Deutsche Bank AG	147,020	$4.43M	0.0%	+40.4%	0.094%
2/17/2025	Cornerstone Select Advisors LLC	63,270	$1.90M	1.8%	N/A	0.041%
2/17/2025	Cetera Investment Advisers	52,199	$1.57M	0.0%	-1.0%	0.034%
2/17/2025	Brevan Howard Capital Management LP	15,042	$0.45M	0.0%	N/A	0.010%
2/17/2025	Captrust Financial Advisors	7,562	$0.23M	0.0%	-75.1%	0.005%
2/17/2025	Balyasny Asset Management L.P.	9,100	$0.27M	0.0%	N/A	0.006%
2/17/2025	Baird Financial Group Inc.	56,129	$1.69M	0.0%	+7.6%	0.036%
2/17/2025	Bank of America Corp DE	230,939	$6.95M	0.0%	-86.4%	0.148%
2/17/2025	BNP Paribas Financial Markets	59,710	$1.80M	0.0%	-49.4%	0.038%
2/17/2025	Ameriprise Financial Inc.	459,037	$13.80M	0.0%	-0.1%	0.295%
2/17/2025	Algert Global LLC	49,061	$1.48M	0.0%	-52.9%	0.032%
2/17/2025	683 Capital Management LLC	697,000	$20.98M	1.3%	-38.6%	0.448%
2/14/2025	Freestone Grove Partners LP	7,433	$0.22M	0.0%	N/A	0.005%
2/14/2025	PDT Partners LLC	32,187	$0.97M	0.1%	-46.9%	0.021%
2/14/2025	Lido Advisors LLC	7,680	$0.23M	0.0%	N/A	0.005%
2/14/2025	Northern Trust Corp	1,532,929	$46.14M	0.0%	+8.6%	0.985%
2/14/2025	The Manufacturers Life Insurance Company	75,327	$2.27M	0.0%	-4.9%	0.048%
2/14/2025	Artia Global Partners LP	54,515	$1.64M	0.6%	N/A	0.035%
2/14/2025	Boothbay Fund Management LLC	85,360	$2.57M	0.1%	N/A	0.055%
2/14/2025	Susquehanna Fundamental Investments LLC	9,650	$0.29M	0.0%	N/A	0.006%
2/14/2025	Virtus ETF Advisers LLC	11,393	$0.34M	0.1%	-42.0%	0.007%
2/14/2025	Gilder Gagnon Howe & Co. LLC	81,292	$2.45M	0.0%	+25.3%	0.052%
2/14/2025	Voya Investment Management LLC	273,739	$8.24M	0.0%	+398.0%	0.176%
2/14/2025	Penn Capital Management Company LLC	351,408	$10.58M	1.0%	N/A	0.226%
2/14/2025	Syon Capital LLC	9,157	$0.28M	0.0%	N/A	0.006%
2/14/2025	Hood River Capital Management LLC	1,455,323	$43.81M	0.6%	-10.7%	0.935%
2/14/2025	Price T Rowe Associates Inc. MD	297,101	$8.94M	0.0%	+264.5%	0.191%
2/14/2025	State of Tennessee Department of Treasury	59,883	$1.80M	0.0%	+28.4%	0.038%
2/14/2025	Tower Research Capital LLC TRC	32,498	$0.98M	0.0%	+937.6%	0.021%
2/14/2025	MYDA Advisors LLC	55,000	$1.66M	0.4%	+37.5%	0.035%
2/14/2025	MetLife Investment Management LLC	84,360	$2.54M	0.0%	+4.7%	0.054%
2/14/2025	First Trust Advisors LP	275,496	$8.29M	0.0%	+871.7%	0.177%
2/14/2025	Commerce Bank	6,789	$0.20M	0.0%	N/A	0.004%
2/14/2025	Altium Capital Management LLC	95,000	$2.86M	0.8%	N/A	0.061%
2/13/2025	CANADA LIFE ASSURANCE Co	128,637	$3.87M	0.0%	-2.8%	0.083%
2/13/2025	NewEdge Advisors LLC	6,928	$0.21M	0.0%	+4,549.7%	0.004%
2/13/2025	EAM Investors LLC	128,923	$3.88M	0.6%	-26.7%	0.083%
2/13/2025	Guggenheim Capital LLC	41,461	$1.25M	0.0%	-26.4%	0.027%
2/13/2025	XTX Topco Ltd	13,304	$0.40M	0.0%	N/A	0.009%
2/13/2025	Barclays PLC	317,563	$9.56M	0.0%	-8.5%	0.204%
2/13/2025	Summit Investment Advisors Inc.	14,606	$0.44M	0.4%	+3.3%	0.009%
2/13/2025	Synovus Financial Corp	19,500	$0.59M	0.0%	-2.0%	0.013%
2/13/2025	Raymond James Financial Inc.	481,989	$14.51M	0.0%	N/A	0.310%
2/13/2025	Advisory Services Network LLC	10,359	$0.31M	0.0%	+19.5%	0.007%
2/13/2025	Legal & General Group Plc	391,388	$11.78M	0.0%	-1.8%	0.251%
2/13/2025	Invesco Ltd.	929,743	$27.99M	0.0%	+1.2%	0.597%
2/13/2025	Bank of Montreal Can	20,016	$0.60M	0.0%	+7.3%	0.013%
2/13/2025	Shakespeare Wealth Management LLC	7,398	$0.22M	0.1%	N/A	0.005%
2/13/2025	Federated Hermes Inc.	130,688	$3.93M	0.0%	+25.9%	0.084%
2/13/2025	Quadrant Capital Group LLC	1,686	$51K	0.0%	+137.1%	0.001%
2/13/2025	Russell Investments Group Ltd.	34,706	$1.05M	0.0%	+323.2%	0.022%
2/13/2025	Envestnet Asset Management Inc.	50,111	$1.51M	0.0%	+11.4%	0.032%
2/13/2025	Rhenman & Partners Asset Management AB	262,500	$7.90M	0.8%	+53.1%	0.169%
2/13/2025	Wells Fargo & Company MN	331,403	$9.98M	0.0%	+85.4%	0.213%
2/12/2025	Landscape Capital Management L.L.C.	23,428	$0.71M	0.1%	N/A	0.015%
2/12/2025	Pitcairn Co.	11,745	$0.35M	0.0%	N/A	0.008%
2/12/2025	Headlands Technologies LLC	21,653	$0.65M	0.1%	+494.5%	0.014%
2/12/2025	Geode Capital Management LLC	3,193,505	$96.15M	0.0%	-0.4%	2.052%
2/12/2025	Franklin Resources Inc.	97,538	$2.94M	0.0%	-24.4%	0.063%
2/12/2025	Alliancebernstein L.P.	174,020	$5.24M	0.0%	-10.1%	0.112%
2/12/2025	Wellington Management Group LLP	63,513	$1.91M	0.0%	-13.4%	0.041%
2/12/2025	O Shaughnessy Asset Management LLC	8,617	$0.26M	0.0%	N/A	0.006%
2/12/2025	Clearbridge Investments LLC	1,835,127	$55.24M	0.0%	N/A	1.179%
2/12/2025	Pictet Asset Management Holding SA	2,793,931	$84.10M	0.1%	-22.0%	1.795%
2/12/2025	New Age Alpha Advisors LLC	7,082	$0.21M	0.0%	N/A	0.005%
2/12/2025	Norges Bank	401,495	$12.09M	0.0%	N/A	0.258%
2/12/2025	WINTON GROUP Ltd	40,436	$1.22M	0.1%	-10.3%	0.026%
2/11/2025	Segall Bryant & Hamill LLC	79,518	$2.39M	0.0%	+51.8%	0.051%
2/11/2025	Prudential Financial Inc.	168,575	$5.07M	0.0%	-44.8%	0.108%
2/11/2025	Corebridge Financial Inc.	74,117	$2.23M	0.0%	-7.2%	0.048%
2/11/2025	Advantage Alpha Capital Partners LP	13,447	$0.41M	0.1%	-39.9%	0.009%
2/11/2025	Vanguard Group Inc.	15,596,480	$469.45M	0.0%	+1.4%	10.020%
2/11/2025	LPL Financial LLC	185,062	$5.57M	0.0%	+61.9%	0.119%
2/11/2025	Simplify Asset Management Inc.	11,237	$0.34M	0.0%	N/A	0.007%
2/11/2025	KLP Kapitalforvaltning AS	30,700	$0.92M	0.0%	N/A	0.020%

Data available starting January 2016

See Full Table

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.

Today's Range

Now: $39.86

$38.78

$40.56

50 Day Range

MA: $34.37

$28.53

$42.99

52 Week Range

Now: $39.86

$12.93

$43.32

Volume

1,642,962 shs

Average Volume

3,069,404 shs

Market Capitalization

$6.26 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.3

Who are the company insiders with the largest holdings of TG Therapeutics?: TG Therapeutics' top insider investors include:
Michael S Weiss (CEO)
Sean A Power (CFO)
Laurence N Charney (Director)
Sagar Lonial (Director)
Learn More about top insider investors at TG Therapeutics.
Who are the major institutional investors of TG Therapeutics?: TG Therapeutics' top institutional shareholders include:
Vanguard Group Inc. — 10.02%
Geode Capital Management LLC — 2.05%
Pictet Asset Management Holding SA — 1.79%
Soleus Capital Management L.P. — 1.72%
Clearbridge Investments LLC — 1.18%
Nuveen Asset Management LLC — 1.16%
Learn More about top institutional investors of TG Therapeutics stock.
Which institutional investors are selling TG Therapeutics stock?: In the previous quarter, TGTX stock was sold by these institutional investors:
Bank of America Corp DE
Pictet Asset Management Holding SA
Two Sigma Investments LP
683 Capital Management LLC
Citadel Advisors LLC
Nuveen Asset Management LLC
Two Sigma Advisers LP
Hood River Capital Management LLC
In the previous year, company insiders that have sold TG Therapeutics company stock include:
Michael S Weiss (CEO)
Sean A Power (CFO)
Learn More investors selling TG Therapeutics stock.
Which institutional investors are buying TG Therapeutics stock?: In the last quarter, TGTX stock was bought by institutional investors including:
Clearbridge Investments LLC
Raymond James Financial Inc.
Raymond James Financial Inc.
Braun Stacey Associates Inc.
Susquehanna International Group LLP
Norges Bank
Penn Capital Management Company LLC
Jane Street Group LLC